Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.
作者信息
Kemeny N E, Schneider A, Martin D S
机构信息
Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
出版信息
Cancer Invest. 1990;8(2):263-4. doi: 10.3109/07357909009017578.
PMID:2400946
Abstract
摘要
Zotero 插件